Please login to the form below

Not currently logged in
Email:
Password:

Merck KGaA adds two to its executive board

Appoints Udit Batra and Walter Galinat, while Bernd Reckmann will retire

Merck KGaA Udit BatraMerck KGaA has appointed two new members to its executive board, adding the head of its life science business sector Udit Batra (pictured right) and Walter Galinat (pictured below), who heads up its performance materials business sector.

The move means that, following the reorganisation of Merck's businesses last year, each sector will now have its own representative on the company's executive board.

It will also see Bernd Reckmann, currently executive board member for life science and performance materials, retire at the German pharma firm's annual general meeting in April.

Johannes Baillou, chairman of the board of partners of E. Merck KG, said: "During Bernd Reckmann's term of office as the responsible executive board member, Merck built the Life Science business from modest beginnings, creating a global market leader. He also orchestrated the development of our Performance Materials business into a world-class technology and innovation powerhouse. 

Merck KGaA Walter Galinat"The owners of the company are grateful to Bernd Reckmann and thank him for his many years of untiring commitment and loyalty. We trust that with Udit Batra and Walter Galinat, the Merck success story will continue, especially since both executives have been superbly managing their respective businesses for multiple years." 

Galinat (pictured left) joined Merck in 1976 and was appointed as head of the company's former Liquid Crystals division in 2007, becoming CEO and president of the Performance Materials business in 2010.

Meanwhile, Batra started his career with Merck's US namesake, before joining Novartis and holding senior roles in market access and strategy. He joined Merck in 2011 to lead its Consumer Health business and in March 2014 was appointed CEO and president of its life science business Merck Millipore.

20th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics